Bioreactors

Subscribe to Selected New Research on Bioreactors

256 relevant articles (9 outcomes, 29 trials/studies) found for this Therapy

Description: Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen.

Also Known As:

Bioreactor

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Bioreactors: 256

Technology, Industry, and Agriculture

Technology

Biotechnology

Bioreactors: 256

Experts

1.	Sen, Arindom: 3 articles (01/2008 - 05/2004)
2.	Behie, Leo A: 3 articles (01/2008 - 05/2004)
3.	Matsuura, Tomokazu: 3 articles (02/2007 - 09/2003)
4.	Maehashi, Haruka: 2 articles (02/2007 - 02/2007)
5.	Bentley, William E: 2 articles (01/2007 - 06/2005)
6.	Mendez, Ivar: 1 article (01/2008)
7.	McLeod, Marcus: 1 article (01/2008)
8.	Lewington, Matthew: 1 article (01/2008)
9.	Baghbaderani, Behnam A: 1 article (01/2008)
10.	Phillips, Timothy: 1 article (01/2008)

Related Diseases

1.	Liver Failure 12/01/1998 - "In the present study, we investigated the efficacy of the NWF bioreactor in a direct hemoperfusion experiment conducted to treat pigs with liver failure" 04/01/2001 - "Efficacy of nonwoven fabric bioreactor immobilized with porcine hepatocytes for ex vivo xenogeneic perfusion treatment of liver failure in dogs." 12/01/1998 - "Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs." 02/01/2008 - "This study suggests that this radial flow bioreactor with stacked microgrooved substrates is scalable and may have potential as a BAL device in the treatment of liver failure." 07/01/1996 - "Metabolic evaluation of cultured porcine hepatocyte monolayers in human plasma from hepatic failure patients--basic study on development of a bioreactor in hybrid artificial liver.]" Order ALL the reference details at left...
2.	Acute Liver Failure (Fulminant Hepatic Failure) 08/01/2003 - "The results obtained indicate that the bioreactor containing small liver fragments is effective in the treatment of acute hepatic failure in animals." 09/01/2003 - "The objective of this study was to evaluate the feasibility and safety of a hybrid liver support system with extracorporeal plasma separation and bioreactor perfusion in patients with acute liver failure (ALF) who had already fulfilled the criteria for high urgency liver transplantation (LTx)" 03/01/2002 - "Inclusion criteria for the study are patients with acute liver failure, any etiology, presenting with encephalopathy deteriorating beyond Parson's Grade 2. The BLSS consists of a blood pump; a heat exchanger to control blood temperature; an oxygenator to control oxygenation and pH; a bioreactor; and associated pressure and flow alarm systems" 11/01/2005 - "Bioreactors containing porcine or adult human hepatocytes have been used to sustain acute liver failure patients until liver transplantation" 07/01/2003 - "The bioartificial liver system, which utilized blood perfusion through a hollow fiber bioreactor from BIOLIV A3A inoculated with 1.0 - 3.1 x 1010 porcine hepatocyte spheroids, was developed for the treatment of acute liver failure" Order ALL the reference details at left...
3.	Infection 11/01/1998 - "Subsequent studies focused on the infection, virus production and harvest from suspension culture bioreactors" 01/01/2008 - "Thus, the presented method is believed to be quite independent of the concentration of infected cells (multiplicity of infection and total cell concentration) in bioreactors" 01/01/2008 - "CONCLUSION: It is shown that flow cytometry is a sensitive and robust method for the monitoring of viral infection in fixed cells from bioreactor samples" 01/01/2008 - "At high multiplicity of infection in a bioreactor, the onset of viral protein accumulation in adherent cells on microcarriers was detected at about 2 to 4 h post infection by flow cytometry" 11/01/2007 - "This technology uses three different BEVs (Bac-Rep, Bac-GFP, and Bac-VP) each at a multiplicity of infection (MOI) of 3. We reported previously the production of rAAV at 40 L scale using a stirred-tank bioreactor (STB)" Order ALL the reference details at left...
4.	Hepatitis 05/01/1997 - "In hepatology, transplantation, and vaccination for hepatitides will increase, and improved treatment of acute liver failure may involve bioreactors or cryopreserved human hepatocytes" 06/01/2003 - "TECA hybrid artificial liver support system (TECA-HALSS), which combines the hollow fiber bioreactor with a plasma exchange circuit, was used to assess the efficacy, safety and feasibility in treating severe hepatitis patients" 10/05/1996 - "A xenogeneic hollow fiber bioreactor utilizing collagen-entrapped dispersed hepatocytes has been developed as an extracorporeal bioartificial liver (BAL) for potential treatment of acute human fulminant hepatitis" Order ALL the reference details at left...
5.	Mucopolysaccharidoses 12/01/2004 - "Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor." 12/01/2004 - "METHODS: In comparison with a conventional bag transduction protocol, a 'closed' hollow-fiber bioreactor system (HBS) was exploited to culture and transduce human peripheral blood CD34(+) progenitor cells (PBPC(MPS)) from patients with mucopolysaccharidosis type I (MPS I) using an amphotropic retroviral vector based on a murine Moloney leukemia virus LN prototype" 11/20/1999 - "Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II." 11/20/1999 - "Toward developing a clinical trial of lymphocyte gene therapy for mucopolysaccharidosis type II (i.e., Hunter syndrome), we investigated a novel method that exploited the innate capability of a hollow-fiber bioreactor system to filter large quantities of vector supernatant and facilitate transduction" Order ALL the reference details at left...

Related Drugs and Biologics

1.	glucuronyl glucosamine glycan sulfate (Vessel)
2.	Immunoglobulins (Immunoglobulin)
3.	Glucose (Dextrose)
4.	Glutamine (L-Glutamine)
5.	Antigens
6.	Glutamate-Ammonia Ligase (Glutamine Synthetase)
7.	GM237354
8.	sordarin
9.	Monoclonal Antibodies
10.	Vaccines

Related Therapies and Procedures

1.	Artificial Liver (Bioartificial Liver)
2.	Hemoperfusion
3.	Transplantation (Transplant Recipients)
4.	Oxygenators
5.	Liver Transplantation

Best Treatments:
Research Summary Report
on Liver Failure

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 175 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>